DRDO-developed technology behind critical drug approved by DCGI for radiological and nuclear emergencies

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.

ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024

Source: The post is based on the articleDRDO-developed technology behind critical drug approved by DCGI for radiological and nuclear emergencies published in The Hindu on 16th March 2023

What is the News?

The Defence Ministry has announced that the Prussian blue insoluble formulations drug has been granted approval by the Drugs Controller General of India(DCGI).

What is a Prussian blue insoluble formulation drug?

It is one of the critical medicines listed by the World Health Organisation(WHO) for radiological and nuclear emergencies.  

It is used to treat the symptoms of Cesium or Thallium Contamination. 

The drug was developed under the Technology Development Fund(TDF).

The drug has been developed based on the technology of the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, a laboratory of the DRDO.

What is Technology Development Fund(TDF)?

Click Here to read

Print Friendly and PDF
Blog
Academy
Community